A combined continuous and interval aerobic training improves metabolic syndrome risk factors in men

International Journal of General Medicine

Volumn 8, Issue , 2015, Pages 203-210

  Sari Sarraf, Vahid ^a   Aliasgarzadeh, Akbar ^b   Naderali, Mohammad Mahdi ^c   Esmaeili, Hamid ^a   Naderali, Ebrahim K ^d  

^a UNIVERSITY OF TABRIZ   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^d LIVERPOOL HOPE UNIVERSITY   (United Kingdom)

Author keywords

Blood pressure; Combined continuous and interval training; Insulin sensitivity; Metabolic syndrome

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; TRIACYLGLYCEROL;

ADULT; AEROBIC EXERCISE; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTINUOUS AEROBIC TRAINING; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; INTERVAL AEROBIC TRAINING; LIFESTYLE MODIFICATION; LIPOPROTEIN BLOOD LEVEL; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MUSCLE STRENGTH; OUTCOME ASSESSMENT; OXYGEN CONSUMPTION; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; RISK REDUCTION; SKELETAL MUSCLE; THERAPY EFFECT; THIGH MUSCLE; TREADMILL EXERCISE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

EID: 84930654550     PISSN: None     EISSN: 11787074     Source Type: Journal    
DOI: 10.2147/IJGM.S81938     Document Type: Article

References (45)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595–1607.
2. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on scientific issues related to definition. Circulation. 2004;109:433–438.
3. Azizi F, Salehi P, Etemadi A, Zahedi-Asl S. Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract. 2003;61:29–37.
4. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA. 2002;287:356–359.
5. Isomaa B, Almgren P, Tuomi T, etal. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24: 683–689.
6. Koren-Morag N, Goldbourt U, Tanne D. Relation between the metabolic syndrome and ischemic stroke or transient ischemic attack: a prospective cohort study in patients with atherosclerotic cardiovascular disease. Stroke. 2005;36:1366–1371.
7. Tkác I. Metabolic syndrome in relationship to type 2 diabetes and atherosclerosis. Diabetes Res Clin Pract. 2005;68(Suppl 1):2–9.
8. Tjønna AE, Lee SJ, Rognmo Ø, et al. Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome a pilot study. Circulation. 2008;118:346–354.
9. Irving BA, Davis CK, Brock DW, et al. Effect of exercise training intensity on abdominal visceral fat and body composition. Med Sci Sports Exerc. 2008;40:1863–1872.
10. Yang X, Telama R, Hirvensalo M, Mattsson N, Viikari JS, Raitakari OT. The longitudinal effects of physical activity history on metabolic syndrome. Med Sci Sports Exerc. 2008;40:1424–1431.
11. O’Leary VB, Marchetti CM, Krishnan RK, Stetzer BP, Gonzalez F, Kirwan JP. Exercise-induced reversal of insulin resistance in obese elderly is associated with reduced visceral fat. J Appl Physiol. 2006;100: 1584–1589.
12. Okauchi Y, Nishizawa H, Funahashi T, et al. Reduction of visceral fat is associated with decrease in the number of metabolic risk factors in Japanese men. Diabetes Care. 2007;30:2392–2394.
13. LaMonte MJ, Barlow CE, Jurca R, Kampert JB, Church TS, Blair SN. Cardiorespiratory fitness is inversely associated with the incidence of metabolic syndrome: a prospective study of men and women. Circulation. 2005;112:505–512.
14. Okura T, Nakata Y, Ohkawara K, et al. Effects of aerobic exercise on metabolic syndrome improvement in response to weight reduction. Obesity. 2007;15:2478–2484.
15. Jurca R, Lamonte MJ, Church TS, etal. Associations of muscle strength and aerobic fitness with metabolic syndrome in men. Med Sci Sports Exerc. 2004;36:1301–1307.
16. Hsu C-N, Chen Y-C, Wang T-D. Prevalence and characteristics of the metabolic syndrome in Chinese hypertensive patients: a hospital-based observation. Acta Cardiol Sin. 2005;21:89–97.
17. Lee JM, Kim SR, Yoo SJ, Hong OK, Son HS, Chang SA. The relationship between adipokines, metabolic parameters and insulin resistance in patient with metabolic syndrome and type 2 diabetes. J Int Med Res. 2009;37:1803–1812.
18. Menuet R, Lavie CJ, Milani RV. Importance and management of dyslipidaemia in the metabolic syndrome. Am J Med Sci. 2005;330:295–302.
19. Lakka TA, Laaksonen DE. Physical activity in prevention and treatment of the metabolic syndrome. Appl Physiol Nutr Metab. 2007;32:76–88.
20. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood Cholesterol (adult treatment panel III). JAMA. 2001;285:2486–2497.
21. Malekshah AF, Kimiagar M, Saadatian-Elahi M, etal. Validity and reliability of a new food frequency questionnaire compared to 24 h recalls and biochemical measurements: pilot phase of Golestan cohort study of esophageal cancer. Eur J Clin Nutr. 2006;60:971–977.
22. Lippincott N, Williams Y. ACSM’s Guidelines for Exercise Testing and Prescription. 7th ed. New York: American College of Sports Medicine; 2005.
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419.
24. Katz A, Nambi SS, Mather K, etal. Qunatitative inulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrionl Metab. 2000;85:402–410.
25. Heyward VH. Advanced Fitness Assessment and Exercise Prescription. 5th ed. Leeds: Human Kinetics Europe Ltd; 2006.
26. Cohn SH, Vaswani A, Zanzi I, Aloia JF, Roginsky MS, Ellis KJ. (1976) Changes in body chemical composition with age measured by total-body neutron activation. Metabolism. 1976;25:85–95.
27. Obesity. World Heart Federation. Available from: http://www.world-heart-federation.org/cardiovascular-health/cardiovascular-disease-risk-factors/obesity/. Accessed December 21, 2014.
28. Naderali EK. Obesity and cardiovascular dysfunction: a role for resveratrol? Obes Res Clin Pract. 2009;3(1):1–5.
29. Naderali EK, Fatani S, Williams G. Chronic withdrawal of a high-palatable obesity-inducing diet completely reverses metabolic and vascular abnormalities associated with dietary-obesity in the rat. Atherosclerosis. 2004;172:63–69.
30. Su X, Magkos F, Zhou D, et al. Adipose tissue monomethyl branched-chain fatty acids and insulin sensitivity: effects of obesity and weight loss. Obesity. 2015;23(2):329–334.
31. Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia. 2011;54:2506–2514.
32. Sartorio A, Fontana P, Trecate L, Lafortuna CL. Short-term changes of fatigability and muscle performance in severe obese patients after an integrated body mass reduction program. Diabetes Nutr Metab. 2003;16:88–93.
33. Fatani S, Abubakari AR, Itua I, Wong C, Thomas C, Naderali EK. Effects of diet-induced obesity on protein expression in insulin signalling pathways of skeletal muscle in male Wistar rats. Int J Gen Med. 2012;5:573–582.
34. Albers PH, Pedersen AJ, Birk JB, et al. Human muscle fiber type specific insulin signaling – impact of obesity and type 2 diabetes. Diabetes. 2015;64(2):485–497.
35. Horowitz JF. Fatty acid mobilization from adipose tissue during exercise. Trends Endocrinol Metab. 2003;14:386–392.
36. Lazzer S, Lafortuna C, Busti C, et al. Fat oxidation rate during and after a low – or high – intensity exercise in severely obese Caucasian adolescents. Eur J Appl Physiol. 2009;10:1007–1234.
37. Jeukendrup AE, Achten J. Fatmax: a new concept to optimize fat oxidation during exercise? Eur J Sport Sci. 2001;5:1–5.
38. Cuff DJ, Meneilly GS, Martin A, Ignaszewski A, Tildesley HD, Frohlich JJ. Effective exercise modality to reduce insulin resistance in women with type 2 diabetes. Diabetes Care. 2003;26:2977–2982.
39. Lambers S, Van Laethem C, Van Acker K, Calders P. Influence of combined exercise training on indices of obesity, diabetes and cardiovascular risk in type 2 diabetes patients. Clin Rehabil. 2008;22: 483–492.
40. Capostagno B, Bosch A. Higher fat oxidation in running than cycling at the same exercise intensities. Int J Sport Nutr Exerc Metab. 2010;20: 44–55.
41. Nyholm B, Mengel A, Nielsen S, et al. Insulin resistance in relatives of NIDDM patients: the role of physical fitness and muscle metabolism. Diabetologia. 1996;39:813–822.
42. Blair SN, Brodney S. Effects of physical inactivity and obesity on morbidity and mortality: current evidence and research issues. Med Sci Sports Exerc. 1999;31:646–662.
43. Vatten LJ, Nilsen TI, Romundstad PR, Droyvold WB, Holmen J. Adiposity and physical activity as predictors of cardiovascular mortality. Eur J Cardiovasc Prev Rehabil. 2006;13:909–915.
44. Nemoto K, Gen-No H, Masuki S, Okazaki K, Nose H. Effects of high- intensity interval walking training on physical fitness and blood pressure in middle – aged and older people. Mayo Clin Proc. 2007;82: 803–811.
45. Singer GM, Setaro JF. Secondary hypertension: obesity and the metabolic syndrome. Clin Hypertens. 2008;10:567–574.